The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
Open accessAbstract
Background—: This randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes compare primary DES versus percutaneous transluminal angioplasty (PTA), overall DES (primary and provisional) versus standard care (PTA and provisional Zilver bare metal stent [BMS]), and provisional DES versus provisional BMS. Methods and Results—: Patients with symptomatic femoropopliteal artery disease were randomly assigned to DES (n=236) or PTA (n=238). Approximately 91% had claudication; 9% had critical limb ischemia. Patients experiencing acute PTA failure underwent secondary randomization to provisional BMS (n=59) or DES (n=61). The 1-year primary end points of event-free survival and patency showed superiority of primary DES in comparison with PTA; these results were sustained through 5 years. Clinical benefit (freedom from persistent or worsening symptoms of ischemia; 79.8% versus 59.3%, P <0.01), patency (66.4% versus 43.4%, P <0.01), and freedom from reintervention (target lesion revascularization, 83.1% versus 67.6%, P <0.01) for the overall DES group were superior to standard care in nonrandomized comparisons. Similarly, clinical benefit (81.8% versus 63.8%, P =0.02), patency (72.4% versus 53.0%, P =0.03), and freedom from target lesion revascularization (84.9% versus 71.6%, P =0.06) with provisional DES were improved over provisional BMS. These results represent >40% relative risk reduction for restenosis and target lesion revascularization through 5 years for the overall DES in comparison with standard care and for provisional DES in comparison with provisional BMS. Conclusions—: The 5-year results from this large study provide long-term information previously unavailable regarding endovascular treatment of femoropopliteal artery disease. The Zilver PTX DES provided sustained safety and clinical durability in comparison with standard endovascular treatments. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00120406.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery
Schillinger, M., Sabeti, S., Loewe, C., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., Cejna, M., Lammer, J., & Minar, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051303 · Cited by 1,157
Lee, E. W., Wei, L. J., Amato, D. A., & Leurgans, S. (1992) · Survival Analysis: State of the Art · doi:10.1007/978-94-015-7983-4_14 · Cited by 688
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
Rosenfield, K., Jaff, M. R., White, C. J., Rocha-Singh, K., Mena-Hurtado, C., Metzger, D. C., Brodmann, M., Pilger, E., Zeller, T., Krishnan, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406235 · Cited by 686
Self-citationTepe, G., Laird, J., Schneider, P., Brodmann, M., Krishnan, P., Micari, A., Metzger, C., Scheinert, D., Zeller, T., Cohen, D. J., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011004 · Cited by 685
Self-citationLaird, J. R., Katzen, B. T., Scheinert, D., Lammer, J., Carpenter, J., Buchbinder, M., Dave, R., Ansel, G., Lansky, A., Cristea, E., et al. (2010) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.109.903468 · Cited by 627
Self-citationDake, M. D., Ansel, G. M., Jaff, M. R., Ohki, T., Saxon, R. R., Smouse, H. B., Zeller, T., Roubin, G. S., Burket, M. W., Khatib, Y., et al. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.111.962324 · Cited by 569
Self-citationSchillinger, M., Sabeti, S., Dick, P., Amighi, J., Mlekusch, W., Schlager, O., Loewe, C., Cejna, M., Lammer, J., & Minar, E. (2007) · Circulation · doi:10.1161/circulationaha.107.688341 · Cited by 501
Duda, S. H., Bosiers, M., Lammer, J., Scheinert, D., Zeller, T., Tielbeek, A., Anderson, J., Wiesinger, B., Tepe, G., Lansky, A., et al. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000151260.74519.ca · Cited by 409
Self-citationWerk, M., Albrecht, T., Meyer, D.-R., Ahmed, M. N., Behne, A., Dietz, U., Eschenbach, G., Hartmann, H., Lange, C., Schnorr, B., et al. (2012) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.112.971630 · Cited by 361
Laird, J. R., Katzen, B. T., Scheinert, D., Lammer, J., Carpenter, J., Buchbinder, M., Dave, R., Ansel, G., Lansky, A., Cristea, E., et al. (2012) · Journal of Endovascular Therapy · doi:10.1583/11-3627.1 · Cited by 300
Self-citation
Cited by
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M., & Karnabatidis, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.011245 · Cited by 1,020
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000471 · Cited by 1,020
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.07.018 · Cited by 963
Metadata
- Authors
- Dake, M. D., Ansel, G. M., Jaff, M. R., Ohki, T., Saxon, R. R., Smouse, H. B., Machan, L. S., Snyder, S. A., O’Leary, E. E., Ragheb, A. O., & Zeller, T.
- Venue
- Circulation
- Published
- 2016-04-12
- Volume
- 133
- Issue
- 15
- Pages
- 1472-1483
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2295508527
- Cited by
- 528
- References
- 24
- FWCI
- 63.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. https://app.cochat.ai/papers/10.1161/circulationaha.115.016900
- The paper
- Dake, M. D., Ansel, G. M., Jaff, M. R., Ohki, T., Saxon, R. R., Smouse, H. B., Machan, L. S., Snyder, S. A., O’Leary, E. E., Ragheb, A. O., & Zeller, T. (2016). Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation. https://doi.org/10.1161/circulationaha.115.016900
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.